drugset / Trial / NCT02004626
Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.
Phase 3
Withdrawn
Cristália Produtos Químicos Farmacêuticos Ltda.
Newco Trials Pesquisa Científica Ltda · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Clinical study Phase III, Prospective, Randomized, Controlled, Double-blind, Multicenter, National, Non-inferiority. Its purpose is to determine the noninferiority in efficacy of an investigational product in relation to the product available in the market intended of treating pressure ulcers.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-06
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 0.6 iu | Topical |